{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-075013","form_type":"8-K","ticker":"OSTX","cik":"0001795091","company_name":"OS Therapies Inc","filed_at":"2026-07-02T20:30:21+00:00","discovered_at":"2026-07-02T20:32:01.191204+00:00","generated_at":"2026-07-02T20:32:32.221083+00:00","sec_items":["1.01","2.03","3.02","5.02","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OS Therapies enters $10M convertible note financing with Leonite Fund; appoints Dr. Craig Eagle to board","bullets":["Enters securities purchase agreement for up to $10M senior secured convertible note with Leonite Fund I, LP; first tranche of $1.6M expected July 2, 2026.","Note bears 9% interest, matures 9 months per tranche (max 24 months); conversion price $2.05/share; warrant to buy 1.75M shares at $2.85 through 2031.","Director Karim Galzahr resigns effective June 1, 2026; Dr. Craig Eagle appointed to fill vacancy, currently serves as Chief Medical Advisor.","Proceeds to fund clinical development, regulatory activities, and working capital.","Note secured by substantially all assets (excl. IP); includes negative covenants, anti-dilution adjustments, and 4.99% beneficial ownership limitation."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-075013","json":"https://secwatch.observer/filing/0001213900-26-075013.json","markdown":"https://secwatch.observer/filing/0001213900-26-075013.md","text":"https://secwatch.observer/filing/0001213900-26-075013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1795091/000121390026075013/0001213900-26-075013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1795091/000121390026075013/ea0296868-8k_ostherapies.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-02T20:32:32.221083+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}